Receptor antibodies as novel therapeutics for diabetes.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 22174312.
- Also identified by DOI 10.1126/scitranslmed.3003447 and PMC identifier 4374142.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antibodies to receptors can block or mimic hormone action. Taking advantage of receptor isoforms, co-receptors, and other receptor modulating proteins, antibodies and other designer ligands can enhance tissue specificity and provide new approaches to the therapy of diabetes and other diseases.
Medical subject headings
- Antibodies, Monoclonal
- Diabetes Mellitus, Type 2
- Fibroblast Growth Factors
- Receptor, Fibroblast Growth Factor, Type 1